| Comparison of Lactobacillus crispatus isolates from Lactobacillus-dominated vaginal microbiomes with isolates from microbiomes containing bacterial vaginosis … AA Abdelmaksoud, VN Koparde, NU Sheth, MG Serrano, AL Glascock, ... Microbiology 162 (3), 466-475, 2016 | 82 | 2016 |
| An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma M Tian, AT Cheuk, JS Wei, A Abdelmaksoud, HC Chou, D Milewski, ... The Journal of Clinical Investigation 132 (16), 2022 | 48 | 2022 |
| Association between statin use, the vaginal microbiome, and Gardnerella vaginalis vaginolysin-mediated cytotoxicity AA Abdelmaksoud, PH Girerd, EM Garcia, JP Brooks, LM Leftwich, ... PLoS One 12 (8), e0183765, 2017 | 25 | 2017 |
| Tumor mutation burden, expressed neoantigens and the immune microenvironment in diffuse gliomas G Yu, Y Pang, M Merchant, C Kesserwan, V Gangalapudi, ... Cancers 13 (23), 6092, 2021 | 20 | 2021 |
| A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia KE Masih, RA Gardner, HC Chou, A Abdelmaksoud, YK Song, L Mariani, ... Blood Advances 7 (15), 4218-4232, 2023 | 10 | 2023 |
| SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck N Nigam, B Bernard, S Sevilla, S Kim, MS Dar, D Tsai, Y Robbins, ... Cell reports 42 (7), 2023 | 10 | 2023 |
| Evaluation of the anti-tumor activity of the humanized monoclonal antibody NEO-201 in preclinical models of ovarian cancer KP Zeligs, MP Morelli, JM David, M Neuman, L Hernandez, S Hewitt, ... Frontiers in Oncology 10, 805, 2020 | 9 | 2020 |
| KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma YY Kim, BE Gryder, R Sinniah, ML Peach, JF Shern, A Abdelmaksoud, ... Nature communications 15 (1), 1703, 2024 | 5 | 2024 |
| UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer BS Harrington, R Kamdar, F Ning, S Korrapati, MW Caminear, ... Journal of Experimental & Clinical Cancer Research 42 (1), 270, 2023 | 4 | 2023 |
| Distinct biomarker profiles and TCR sequence diversity characterize the response to PD-L1 blockade in a mouse melanoma model R El Meskini, D Atkinson, A Kulaga, A Abdelmaksoud, M Gumprecht, ... Molecular Cancer Research 19 (8), 1422-1436, 2021 | 3 | 2021 |
| Functionally diverse thymic medullary epithelial cells interplay to direct central tolerance A Ushio, M Matsuda-Lennikov, F Kalle-Youngoue, A Shimizu, ... Cell reports 43 (4), 2024 | 2 | 2024 |
| Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy G Yu, MK Butler, A Abdelmaksoud, Y Pang, YT Su, Z Rae, K Dadkhah, ... Frontiers in Oncology 10, 601452, 2021 | 2 | 2021 |
| TNFR1 signaling promotes pancreatic tumor growth by limiting dendritic cell number and function MS Alam, MM Gaida, HR Witzel, S Otsuka, A Abbasi, T Guerin, ... Cell Reports Medicine 5 (9), 2024 | 1 | 2024 |
| Harnessing arginine metabolism overcomes hyperthermia-induced metabolic dysfunction of CAR T-cells T Kondo, J DuSold, S Achar, S Adebola, P Gonzalez-Menendez, ... The Journal of Immunology 210 (1_Supplement), 66.05-66.05, 2023 | 1 | 2023 |
| Multi-omic analysis identifies mechanisms of resistance to CD19 CAR T-cell therapy in children with acute lymphoblastic leukemia KE Masih, R Gardner, HC Chou, A Abdelmaksoud, YK Song, L Mariani, ... Cancer Research 82 (12_Supplement), 3581-3581, 2022 | 1 | 2022 |
| Local delivery of cholesterol-lowering drugs to treat and prevent bacterial vaginosis KK Jefferson, AA Abdelmaksoud, PH Girerd, G Buck US Patent 10,583,116, 2020 | 1 | 2020 |
| Smyd3-mediated immuno-modulation in HPV-negative head and neck squamous cell carcinoma mouse models DE Tsai, A Lovanov, A Abdelmaksoud, J Akhtar, MS Dar, M Luff, ... Iscience 27 (9), 2024 | | 2024 |
| Dissecting the effects of Smyd3 depletion in the tumor microenvironment of HPV-negative head and neck squamous cell carcinoma mouse models M Patel, D Tsai, A Abdelmaksoud, N Kedei, M Hernandez, B Karim, ... Cancer Research 83 (7_Supplement), 2320-2320, 2023 | | 2023 |
| KDM3B inhibitors disrupt PAX3-FOXO1 oncogenic activity in fusion positive rhabdomyosarcoma. YY Kim, B Gryder, R Sinniah, M Peach, J Shern, A Abdelmaksoud, ... | | 2022 |
| HARNESSING ARGININE METABOLISM TO OVERCOME HYPERTHERMIA-INDUCED METABOLIC DYSFUNCTION OF CAR T-CELLS T Kondo, J DuSold, S Achar, S Adebola, P Gonzalez-Menendes, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 10, A368-A369, 2022 | | 2022 |
